XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Note 14 - Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
  

Year ended December 31,

 
  

2020

  

2021

  

2022

 

Domestic taxes:

            

Current

 $12  $5  $949 

Deferred

     (1,536)  (4,425)

Foreign taxes:

            

Current

  6,337   11,772   6,647 

Deferred

  (1,449)  (4,949)  14,904 
  $4,900  $5,292  $18,075 
             

Income (loss) before taxes on income:

            

Domestic

 $(6,348) $(14,883) $(22,046)

Foreign

  8,869   20,571   16,938 
  $2,521  $5,688  $(5,108)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

Year ended December 31,

 
  

2020

  

2021

  

2022

 

Income (loss) before taxes on income

 $2,521  $5,688  $(5,108)

Theoretical tax at U.S. statutory rate

  529   1,194   (1,073)

Foreign income taxes at rates other than U.S. rate

  810   450   (4,644)

Technological Preferred Enterprise benefits (*)

  22   836    

Subpart F

  359   192   301 

Non-deductible items

  306   340   121 

Non-taxable items

  (690)  (483)  (452)

Taxes for prior years

        (2,257)

Stock-based compensation expense

  (666)  (1,193)  267 

Impacts of GILTI

  644      6,736 

Tax adjustment in respect of difference tax rate of foreign subsidiary

  1,044   108   (8,147)

Foreign withholding taxes

     648   1,390 

Changes in valuation allowance

  2,487   2,575   24,585 

Other, net

  55   625   1,248 

Taxes on income

 $4,900  $5,292  $18,075 
             

(*)  Basic and diluted earnings per share amounts of the benefit resulting from:

            

the “Technological Preferred Enterprise benefits” status

 $0.00  $0.04  $ 
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

As at December 31,

 
  

2021

  

2022

 

Deferred tax assets

        

Operating loss carryforward

 $15,621  $11,517 

Accrued expenses and deferred revenues

  1,951   2,677 

Temporary differences related to R&D expenses

  5,057   14,677 

Equity-based compensation

  2,756   5,623 

Operating leases

  1,737   2,004 

Tax credit carry forward

  10,997   17,212 

Other

  132   1,255 

Total gross deferred tax assets

  38,251   54,965 

Valuation allowance

  (19,288)  (43,873)

Net deferred tax assets

 $18,963  $11,092 
         

Deferred tax liabilities

        

Operating leases

 $1,719  $2,020 

Intangible assets

  1,394   473 

Total deferred tax liabilities

 $3,113  $2,493 
         

Net deferred tax assets (*)

 $15,850  $8,599 
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
  

Year ended December 31,

 
  

2021

  

2022

 

Beginning of year

 $1,558  $1,610 

Additions for current year tax positions

  133   50 

Reductions for prior year’s tax positions

  (81)  (27)

Balance at December 31

 $1,610  $1,633